Jump to content

Dreading Friday


KarHart

Recommended Posts

Ken goes back to Moffitt on Friday for scans and to see the dr. and possibly a 3rd Avastin infusion. Unfortunately, every time he has a scan it is bad news. He has been on the Tarceva/Avastin for 6 weeks. I suppose if the tumors in the liver are still growing they will stop the treatment. I really don't know where to go after that. I want to look into cyberknife on the liver tumors again, but I think Ken is reaching a state where he just doesn't feel like trying anything else. I can't believe that there just isn't something that could at least help for awhile. We have never even heard the word stable. So,I am dreading Friday.

Link to comment
Share on other sites

Karen, I am so sorry to hear that things aren't going so well for you right now. I can tell how very worried you are from the tone of your posts. I am saying lots of prayers that the news will be good on Friday. Please remember that you can pick up the phone and call me anytime you need to talk.

Link to comment
Share on other sites

Dear Karen,

There is ALWAYS hope and ALWAYS prayer. I am sending both your way...along with some additional strength to see you through this very difficult patch.

Avastin has produced good results for others. Hold onto the hope that it can for you guys as well. I will remain steadfast in the prayer department. Hope the next week or so does not prove to be too difficult for you both.

(((Ken and Karen))),

Kasey

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.